Assessing Brain Tissue Viability on Nonenhanced Computed Tomography After Ischemic Stroke
Stroke · 2023-02 · 54 (2) · 558-566
DOI: 10.1161/strokeaha.122.041241 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stroke, 2023-02. Verfasst von Awad Alzahrani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Clinical Brain Sciences, University of Edinburgh, United Kingdom (A. Alzahrani). Hauptthemen laut MEDLINE: Stroke, Brain Ischemia, Ischemic Stroke. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Treatment for ischemic stroke can be offered beyond conventional time limits for patients with favorable computed tomography perfusion (CTP), but this is not universally available. We sought a threshold for brain attenuation on nonenhanced computed tomography (NECT) to differentiate CTP-defined penumbra vs core, and correlated NECT features with CTP.
Methods
We retrospectively assessed consecutive patients presenting to King Abdulaziz University Hospital with ischemic stroke (2017–2020), baseline NECT, and a visible defect on concurrent CTP. Using CTP as the reference standard, we measured the attenuation of ischemic and healthy contralateral brain on NECT to produce attenuation ratios (ischemic/normal) for penumbra and core. We used area under the receiver operating characteristic curve to estimate the optimal computed tomography (CT) attenuation ratio for penumbra. Per patient, we qualitatively assessed 8 regions within the affected cerebral hemisphere: on NECT as normal, hypoattenuating (with/out swelling), or isolated swelling and on CTP as normal, penumbra, or core. We sought associations between isolated swelling and penumbra, and between hypoattenuation and core.
Results
We include 142 patients (86 male), mean age 61±14 years. Median 261 minutes (interquartile range, 173–382) to NECT. We measured 206 ischemic lesions (124 penumbra, 82 core). Optimal CT attenuation ratio for identifying penumbra was >0.87, with 86% sensitivity 91% specificity (area under the receiver operating characteristic curve, 0.95 [95% CI, 0.92–0.98]; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Clinical Brain Sciences, University of Edinburgh, United Kingdom (A. Alzahrani).
- Department of Diagnostic Radiology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia (A. Alzahrani).
- School of Medicine, University of Dundee, United Kingdom (X.Z.).
- Department of Radiology, King Abdulaziz University Hospital, Jeddah, Saudi Arabia (A. Albukhari).
- Edinburgh Imaging, and UK Dementia Research Institute at the University of Edinburgh and Centre for Clinical Brain Sciences, University of Edinburgh, United Kingdom (J.M.W., G.M.).
ORCID-Profile: Joanna M Wardlaw, Grant Mair
Förderung
- Medical Research Council
Zitieren
APA
Alzahrani, A., Zhang, X., Albukhari, A., Wardlaw, J. M., & Mair, G. (2023). Assessing Brain Tissue Viability on Nonenhanced Computed Tomography After Ischemic Stroke. Stroke, 54(2), 558-566. https://doi.org/10.1161/strokeaha.122.041241
Vancouver
Alzahrani A, Zhang X, Albukhari A, Wardlaw JM, Mair G. Assessing Brain Tissue Viability on Nonenhanced Computed Tomography After Ischemic Stroke. Stroke. 2023;54(2):558-566. doi:10.1161/strokeaha.122.041241
BibTeX
@article{Alzahrani2023,
author = {Alzahrani, Awad and Zhang, Xinyu and Albukhari, Adel and Wardlaw, Joanna M and Mair, Grant},
title = {Assessing Brain Tissue Viability on Nonenhanced Computed Tomography After Ischemic Stroke},
journal = {Stroke},
year = {2023},
volume = {54},
number = {2},
pages = {558--566},
doi = {10.1161/strokeaha.122.041241}
}
EUVIMED